These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 23773289

  • 1. An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model.
    Ma L, Nagai J, Chun J, Ueda H.
    Mol Pain; 2013 Jun 17; 9():29. PubMed ID: 23773289
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
    Ma L, Uchida H, Nagai J, Inoue M, Aoki J, Ueda H.
    J Pharmacol Exp Ther; 2010 May 17; 333(2):540-6. PubMed ID: 20123931
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model.
    Yano R, Ma L, Nagai J, Ueda H.
    Cell Mol Neurobiol; 2013 Nov 17; 33(8):1033-41. PubMed ID: 23949386
    [Abstract] [Full Text] [Related]

  • 5. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H.
    Mol Pain; 2009 Nov 13; 5():64. PubMed ID: 19912636
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systems Pathology of Neuropathic Pain and Fibromyalgia.
    Ueda H.
    Biol Pharm Bull; 2019 Nov 13; 42(11):1773-1782. PubMed ID: 31685762
    [Abstract] [Full Text] [Related]

  • 8. Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain.
    Ma L, Nagai J, Ueda H.
    J Neurochem; 2010 Nov 13; 115(3):643-53. PubMed ID: 20722972
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
    Inoue M, Ma L, Aoki J, Ueda H.
    J Neurochem; 2008 Dec 13; 107(6):1556-65. PubMed ID: 19014389
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
    Lin ME, Rivera RR, Chun J.
    J Biol Chem; 2012 May 18; 287(21):17608-17617. PubMed ID: 22461625
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice.
    Srikanth M, Chew WS, Hind T, Lim SM, Hay NWJ, Lee JHM, Rivera R, Chun J, Ong WY, Herr DR.
    Eur J Pharmacol; 2018 Dec 15; 841():49-56. PubMed ID: 30321532
    [Abstract] [Full Text] [Related]

  • 16. Two pathways for lysophosphatidic acid production.
    Aoki J, Inoue A, Okudaira S.
    Biochim Biophys Acta; 2008 Sep 15; 1781(9):513-8. PubMed ID: 18621144
    [Abstract] [Full Text] [Related]

  • 17. Lysophosphatidic acid as the initiator of neuropathic pain.
    Ueda H.
    Biol Pharm Bull; 2011 Sep 15; 34(8):1154-8. PubMed ID: 21804198
    [Abstract] [Full Text] [Related]

  • 18. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ, Lee KP, Kang S, Chung HY, Bae YS, Okajima F, Im DS.
    Cell Signal; 2013 Nov 15; 25(11):2147-54. PubMed ID: 23838008
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.